刘滔 ,? 严惟力 ,? 黄钢



  • 基金项目:



  • 中图分类号: R814.42;R817.4

The role of PET and PET-CT in the radiotherapy plan

  • CLC number: R814.42;R817.4

  • 摘要: 肿瘤放射治疗已进入PET及PET-CT引导的生物适形治疗时代,PET及PET-CT改进和优化了综合治疗计划的实施,改进了放疗计划的实施目的,精确了肿瘤放疗靶区的制定,同时在靶区勾画过程中大大减少了不同医生所勾画靶区的差异,并减少了勾画靶区的偏倚,通过准确靶区范围而使治疗-效益比提高.
  • [1] Heron DE, Simth RP, Andrade RS. Advancers in image-guided radiation therapy-the role of PET-CT. Med Dosim, 2006, 31(1):3-11.
    [2] Van TinterenH, Hoekstra, OS, Smit EF, et al. Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer:the PLUS multicentre randomized trial. Lancet, 2002, 359(9315):1388-1393.
    [3] Van Westreenen HL, Heeren PA, Van DHM, et al. Positron emission tomography with F-18-fluorodeoxyglucose in a combined staging strategy of esophageal cancer prevents nnnecessary surgical exploraions. J. Gastrointest. Surg, 2005, 9(1):54-61.
    [4] Radan L, Ben-Haim S, Bar-Shalom R, et al. The role of FDG-PETCT in suspected reeurrence of breast cancer. Cancer, 2006, 107(11):2545-2551.
    [5] Huebner RH, Park KC, Shepherd JE, et al. A meta-analysis of the literature for whole-body FDG PET deteetion of reeurrent colorectal cancer. J Nucl Ned, 2000, 41(7):1177-1189.
    [6] Dizendorf EV, Baumert BC, Von Sehulthess GK, et al. Impact of whole-body 18F-FDG PET on staging and managing patients for radiation therapy. J Nucl Med, 2003, 44(1):24-29.
    [7] Ciernik IF, Dizendorf E, Baumert BG, et al. Radiation treatment planning with an integrated positron emission and computer tomography (PET-CT):a feasibility study. Int J Radiat Orxcol Biol Phys, 2003, 57(3):853-863.
    [8] Mourean-Zabotto L, Touboul E, Lerouge D, et al. Impact of CT and 18F-deoxyglucose positron emission tomography image fusion for conformal radiotherapy in esophageal carcinoma. Int J Radiat Oncol Biol Phys, 2005, 63(2):340-345.
    [9] Zheng XK, Chen LH, Wang QS, et al. Influence of[18F] fluorodeoxyglueose positron emission tomography on salvage trealment decision making for locally persistent nasopharyneal carcinoma. Int J Radiat Oncnl Biol Phys, 2006, 65(4):1020-1025.
    [10] Deniaud-Alexandre E, Touboal E, Lerouge D, et al. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer. IntJ Radiat Oncol Biol Phys, 2005, 63(5):1432-1441.
    [11] Leong T, Everitt C, Yuen K, et al. A prospective study to evaluale the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer. Radiother Oncol, 2006, 78(3):254-261.
    [12] Steenbakkers R J, Duppen JC, Fitton I, et al. Reduction of observer variation using matched CT-PET for lung cancer delineation:A three-dimensinnal analysis. Int J Radiat Oneol Biol Phys, 2006, 64(2):435-448.
    [13] Paulino AC, Koshy M, Howell R, et al. Comparison of CT-and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys, 2005, 61(5):1385-1392.
    [14] VespriniD, UngY, Kamra J, et al.The Addition of 18-fluorodeoxyglueose positron emission tomography (FDG-PET) to CT based radiotherapy planning of carcinoma of the esophagus decreases both the intra and interobserver variability of GTV delineation. Int J Radiat Oncol Biol Phys, 2006, 66(3,suppl):S299-S300.
    [15] Riegel AC, Berson AM, Destian S, et al. Variability of gross tumor volume delineation in head-and-neck cancer using CT and PET-CT fusion. Inl J Radial Oncol Biol Phys, 2006, 65(3):726-732.
    [16] Bradley J, Thorstad WL, Mutic S, et al. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys, 2004, 59(1):78-86.
    [17] Grosu AL, Weber WA, Astner ST, et al. 11C-methionine PET improves the target volume delineation of meningiomas treated with stereotactic fractionated radiotherapy. Int J Radiat Oncol Biol Phys, 2006, 66(2):339-344.
  • [1] 朱苏雨 ,?胡炳强 .?PET-CT用于肿瘤精确放疗靶区勾画的困惑.?国际放射医学核医学杂志, 2007,?31(4):?217-221.
    [2] 孙启和 ,?孙彬 ,?杨永青 .?术中125I粒子植入治疗肿瘤的临床应用.?国际放射医学核医学杂志, 2010,?34(2):?102-104. doi:?10.3760/cma.j.issn.1673-4114.2010.02.011
    [3] 黄劲雄 ,?吴华 .?功能性影像在脑胶质瘤放射治疗靶区确定中的应用.?国际放射医学核医学杂志, 2007,?31(2):?108-112.
    [4] 乔文礼 ,?赵晋华 .?18F-氟脱氧葡萄糖PET在靶区确定和放疗计划制定中的价值.?国际放射医学核医学杂志, 2007,?31(6):?345-349.
    [5] 赵惠扬 .?放射性核素计算机处理断层摄影术.?国际放射医学核医学杂志, 1979,?3(1):?36-41.
    [6] 郭慧敏 ,?赵晋华 .?应用影像学方法评价乳腺癌新辅助化疗疗效.?国际放射医学核医学杂志, 2009,?33(3):?149-153. doi:?10.3760/cma.j.issn.1673-4114.2009.03.006
    [7] 夏伟 ,?罗全勇 ,?袁志斌 .?PET-CT在肿瘤放射治疗中的应用.?国际放射医学核医学杂志, 2006,?30(6):?331-335.
    [8] 隗功华 ,?孙晓光 .?医学影像学在肿瘤治疗疗效评价中的应用.?国际放射医学核医学杂志, 2009,?33(1):?43-46. doi:?10.3760/cma.j.issn.1673-4114.2009.01.043
    [9] 陈香 ,?赵晋华 .?PET及PET-CT在监测肿瘤治疗效果中的价值.?国际放射医学核医学杂志, 2007,?31(6):?354-358.
    [10] 叶慧 ,?莫逸 ,?谢爱民 ,?彭翔 .?18F-氟脱氧葡萄糖PET-CT与99nTc-亚甲基二膦酸盐骨显像诊断转移性骨肿瘤的对比研究.?国际放射医学核医学杂志, 2008,?32(3):?147-150.
    [11] 李林法 .?18F-氟代脱氧葡萄糖正电子发射体层显像在感染与炎症病变中的应用.?国际放射医学核医学杂志, 2006,?30(1):?26-29.
    [12] 杨吉刚 ,?李春林 .?18F-氟脱氧葡萄糖PET及PET-CT在食管癌中的.?国际放射医学核医学杂志, 2007,?31(1):?31-33.
    [13] 赵晋华 ,?郭慧敏 .?综合应用临床影像学对乳腺癌进行筛查、诊断和分期.?国际放射医学核医学杂志, 2009,?33(4):?222-225. doi:?10.3760/cma.j.issn.1673-4114.2009.04.009
    [14] 张玉娜 ,?赵晋华 .?18F-氟脱氧葡萄糖PET-CT在头颈部肿瘤临床诊治中的价值.?国际放射医学核医学杂志, 2007,?31(6):?359-362.
    [15] 任树华 ,?华逢春 ,?赵军 .?PET-CT乏氧显像及其在肺癌中的研究进展.?国际放射医学核医学杂志, 2008,?32(5):?286-290.
    [16] 张悦 .?18F-氟脱氧葡萄糖PET和PET-CT在结直肠癌术后复发或转移中的应用价值.?国际放射医学核医学杂志, 2007,?31(1):?34-36.
    [17] 宋建华 ,?赵晋华 ,?邢岩 .?胸、腹部肿瘤PET-CT扫描方案的设置与选择.?国际放射医学核医学杂志, 2007,?31(6):?349-353.
    [18] 司宏伟 ,?耿建华 ,?陈盛祖 .?核医学显像与呼吸门控.?国际放射医学核医学杂志, 2007,?31(2):?104-107.
    [19] 黄建敏 ,?潘莉萍 ,?李冬雪 .?PET和PET-CT在宫颈癌中的应用价值.?国际放射医学核医学杂志, 2007,?31(2):?112-114.
    [20] 赵德善 ,?乔振华 .?18F-氟脱氧葡萄糖PET-CT在淋巴瘤中的应用价值.?国际放射医学核医学杂志, 2007,?31(3):?141-144.
  • 加载中
  • 文章访问数:? 68
  • HTML全文浏览量:? 1
  • PDF下载量:? 2
  • 收稿日期:? 2007-03-21


  • 1. 200127 上海, 上海交通大学医学院附属仁济医院核医学科;
  • 2. 200127 上海, 上海交通大学医学院临床核医学研究所
基金项目:? 上海市教委重点发展基金项目(04BA03)上海市科委重点基金项目(04JC14044)


English Abstract

参考文献 (17)